{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001485003","name":"Carisma Therapeutics Inc.","summary":"Carisma Therapeutics Inc. is a biotechnology company focused on macrophage and monocyte engineering to develop therapies for liver fibrosis and cancer. Its proprietary CAR-M platform uses chimeric antigen receptors to redirect macrophages against tumor-associated antigens. Key candidates include CT-2401 (liver fibrosis, mRNA/LNP approach) and CT-1119 (mesothelin-positive solid tumors). Following strategic reviews in 2024-2025, the company paused R&D and is exploring strategic alternatives including asset sales, partnerships, or a company merger.","people":[],"products":[{"name":"CT-2401","type":"platform","description":"mRNA/LNP-based product candidate targeting liver fibrosis via engineered macrophages; achieved pre-clinical proof of concept in Q2 2024."},{"name":"CT-1119","type":"platform","description":"Mesothelin-targeted CAR-Monocyte product candidate for advanced solid tumors including pancreatic, ovarian, and lung cancer; development paused."},{"name":"CT-0525","type":"platform","description":"HER2-directed CAR-Monocyte autologous cell therapy for solid tumors; development ceased in December 2024 after Phase 1 trial."},{"name":"CT-0508","type":"platform","description":"Macrophage-based initial lead product candidate; all clinical activities ceased as of the 2024 revised operating plan."},{"name":"CAR-M Platform","type":"platform","description":"Proprietary chimeric antigen receptor macrophage platform for redirecting macrophages and monocytes against tumor-associated antigens."}],"partnerships":[{"partner_name":"ModernaTX, Inc.","partnership_type":"development","description":"Collaboration on in vivo mRNA/LNP CAR-M programs; Carisma eligible to receive future milestones and royalty payments.","start_date":null}],"affiliations":[],"origin":{"leaf":"bcb342e9199eb7f64ddb571a451fa5ec303b48af592c4abb21c7fa03a0f36846","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"b9c78a1cea0bfa76ec56ad4c8085de32e35d7d0a4ea05d6c468d1c1b664a949c","parent":"5c517cbdacf7b3c3baf4533984eaaf6b1b0baf41d611dec9669633b0b4eca48a","source":"0001628280-25-015673","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":500,"hourly_limit":500,"remaining":0,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}